baclofen has been researched along with n(6)-cyclopentyladenosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Nikbakht, MR; Stone, TW | 1 |
| Kimura, M; Saitoh, N; Takahashi, T | 1 |
| Kloosterman, F; Leung, LS; Poon, N; Wu, C | 1 |
| Mackie, K; Min, KT; Straiker, A | 1 |
5 other study(ies) available for baclofen and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Suppression of presynaptic responses to adenosine by activation of NMDA receptors.
Topics: Action Potentials; Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Baclofen; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; GABA Agonists; Glycine; Hippocampus; In Vitro Techniques; Kainic Acid; Long-Term Potentiation; Male; N-Methylaspartate; Phenethylamines; Presynaptic Terminals; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Time Factors; Triazines; Triazoles | 2001 |
Adenosine A(1) receptor-mediated presynaptic inhibition at the calyx of Held of immature rats.
Topics: Adenosine; Animals; Auditory Pathways; Baclofen; Blotting, Western; Brain Stem; Calcium; Calcium Channels; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; GABA-B Receptor Agonists; Gene Expression Regulation, Developmental; Immunohistochemistry; Neural Inhibition; omega-Conotoxin GVIA; Patch-Clamp Techniques; Potassium; Potassium Channels; Presynaptic Terminals; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Presynaptic; Synaptophysin; Tetrodotoxin; Theophylline | 2003 |
Presynaptic GABA(B) receptors on glutamatergic terminals of CA1 pyramidal cells decrease in efficacy after partial hippocampal kindling.
Topics: Adenosine; Animals; Baclofen; Dose-Response Relationship, Drug; Electrodes, Implanted; Excitatory Postsynaptic Potentials; Extracellular Space; GABA Agonists; Glutamates; Hippocampus; Kindling, Neurologic; Nerve Endings; Pyramidal Cells; Rats; Receptors, GABA-B; Receptors, Presynaptic | 2006 |
Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons.
Topics: Adenosine; Animals; Baclofen; Data Interpretation, Statistical; Electrophysiological Phenomena; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; GABA Agonists; Hippocampus; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Neurons; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Synapses | 2013 |